CD44 and thyroid cancer: CD177, a marker of the proinflammatory neutrophil subset [31], and CD44, which plays an important role in neutrophil adhesion and migration [32], were upregulated both in UTC and advanced-stage thyroid cancer (Fig. 4A, B).